CHAN PHILLIP P. (President and CEO) purchased 17.6% of their position (261.47K shares) of CYTOSORBENTS CORP on the open market
Open‑market purchase worth $104.9K — a significant purchase. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 6/15/2026ACC: 0001104659-26-074164
DirectorOfficer· President and CEO
Since Sep 2018
+261.47K
Net shares
Net buyer
$104.9K
Total acquired
2
Open market trades
2B · 0S
2
Total transactions
261.47K acquired
Non-Derivative Transactions2
Common Stock
Direct
Shares
+251.14K
Price / share
$0.40
Trade value
$100.45K
% of position
16.9%
6/12/2026
1.48M→1.73M
Common Stock
Direct
Shares
+10.33K
Price / share
$0.43
Trade value
$4.44K
% of position
0.6%
6/15/2026
1.73M→1.74M
Total
Net shares
+261.47K
Net value
$104.90K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/12/2026 | P · Purchase | +251.14K | $0.40 | $100.45K | 16.9% | 1.48M | 1.73M |
| Common Stock Direct | 6/15/2026 | P · Purchase | +10.33K | $0.43 | $4.44K | 0.6% | 1.73M | 1.74M |
| Total | +261.47K | $104.90K | ||||||
Derivative Transactions0
No derivative transactions reported